News on Metris Therapeutics Ltd. from BioPortfolio.com http://www.BioPortfolio.com Consolidated Metris Therapeutics Ltd. news from BioPortfolio.com Tue, 09 Feb 2010 18:45:01 GMT en Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036389&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036389&THISHREF=http://c.moreover.com/click/here.pl%3fz2536596320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036389&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036389&THISHREF=http://c.moreover.com/click/here.pl%3fz2536596320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Updates for PPD (Nasdaq:PPDI), Repros Therapeutics (Nasdaq:RPRX), Stem Cell Therapy (OTC:SCII)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035374&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035374&THISHREF=http://c.moreover.com/click/here.pl%3fz2536217918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035374&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035374&THISHREF=http://c.moreover.com/click/here.pl%3fz2536217918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034844&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034844&THISHREF=http://c.moreover.com/click/here.pl%3fz2536010628%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034844&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034844&THISHREF=http://c.moreover.com/click/here.pl%3fz2536010628%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Updates for PPD (Nasdaq:PPDI), Repros Therapeutics (Nasdaq:RPRX), Stem Cell Therapy (OTC:SCII)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033946&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033946&THISHREF=http://c.moreover.com/click/here.pl%3fz2535503936%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033946&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033946&THISHREF=http://c.moreover.com/click/here.pl%3fz2535503936%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Chronicle: Power times twohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032789&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032789&THISHREF=http://c.moreover.com/click/here.pl%3fz2534822731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032789&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032789&THISHREF=http://c.moreover.com/click/here.pl%3fz2534822731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery News: Stem Cell Therapeutics Corp. Announces the Third and Final Positi...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035342&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035342&THISHREF=http://c.moreover.com/click/here.pl%3fz2536208733%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035342&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035342&THISHREF=http://c.moreover.com/click/here.pl%3fz2536208733%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032561&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032561&THISHREF=http://c.moreover.com/click/here.pl%3fz2534705158%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032561&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032561&THISHREF=http://c.moreover.com/click/here.pl%3fz2534705158%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters UK: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032436&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032436&THISHREF=http://c.moreover.com/click/here.pl%3fz2534649486%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032436&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032436&THISHREF=http://c.moreover.com/click/here.pl%3fz2534649486%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032405&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032405&THISHREF=http://c.moreover.com/click/here.pl%3fz2534640453%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032405&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032405&THISHREF=http://c.moreover.com/click/here.pl%3fz2534640453%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034806&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034806&THISHREF=http://c.moreover.com/click/here.pl%3fz2535983966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034806&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034806&THISHREF=http://c.moreover.com/click/here.pl%3fz2535983966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033863&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033863&THISHREF=http://c.moreover.com/click/here.pl%3fz2535458189%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033863&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033863&THISHREF=http://c.moreover.com/click/here.pl%3fz2535458189%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTimes Live South Africa: Cell Therapeutics stock plunges on negative FDA review of cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033480&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033480&THISHREF=http://c.moreover.com/click/here.pl%3fz2535226444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033480&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033480&THISHREF=http://c.moreover.com/click/here.pl%3fz2535226444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeattle Times: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032439&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032439&THISHREF=http://c.moreover.com/click/here.pl%3fz2534652841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032439&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032439&THISHREF=http://c.moreover.com/click/here.pl%3fz2534652841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: UPDATE 5-Cell Therapeutics drug draws US FDA staff concernshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032435&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032435&THISHREF=http://c.moreover.com/click/here.pl%3fz2534649454%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032435&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032435&THISHREF=http://c.moreover.com/click/here.pl%3fz2534649454%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Stem Cell Therapeutics Corp. Announces the Third and Final Positive Review by the Data Safety and Monitoring Bhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035936&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035936&THISHREF=http://c.moreover.com/click/here.pl%3fz2536429089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035936&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Metris%20Therapeutics%20Ltd.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035936&THISHREF=http://c.moreover.com/click/here.pl%3fz2536429089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: